KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer

Published 2008 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 99, Issue 12, Pages 2020-2028
Publisher
Springer Nature
Online
2008-11-19
DOI
10.1038/sj.bjc.6604783

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.